跳至主要内容
临床试验/NCT01622166
NCT01622166已完成不适用

Art Therapy for Symptom Reduction in Acute Schizophrenia - a Randomised Controlled Trial (Kunsttherapie Zur Symptomreduktion Bei Akuter Schizophrenie - Eine Randomisierte Kontrollierte Pilotstudie)

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Change in Positive and Negative Syndrome Scale (PANSS-) scores

研究概览

简要总结

Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.

*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.

*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diagnosis of schizophrenia according to DSM-IV-TR
  • •age 18-64 yrs
  • •sufficient German language competency
  • •written informed consent

排除标准

  • •axis-I mental disorders other than schizophrenia
  • •comorbid antisocial personality disorder, relevant substance abuse,
  • •relevant severe somatic disease
  • •acute suicidal tendencies or aggression
  • •incapability to tolerate group settings

研究组 & 干预措施

art therapy

Experimental

12 sessions of art therapy / 6 weeks

干预措施: psychodynamic art therapy (Behavioral)

TAU

No Intervention

treatment as usual / 6 weeks

结局指标

主要结局

Change in Positive and Negative Syndrome Scale (PANSS-) scores

时间窗: weeks 0, 6, 12

assessment of change of schizophrenic positive, negative and general symptom scores

safety measures

时间窗: weeks 0, 6, 12

number of participants with adverse events

Change in Calgary depression Scale (CDS-) scores

时间窗: weeks 0, 6, 12

assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christiane Montag MD

Principal Investigator

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验